ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
0.64
0.04
(6.67%)
Closed December 28 4:00PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.64
Bid
0.60
Ask
0.65
Volume
12,000
0.60 Day's Range 0.65
0.48 52 Week Range 2.55
Previous Close
0.60
Open
0.60
Last Trade
500
@
0.64
Last Trade Time
Average Volume (3m)
25,464
Financial Volume
-
VWAP
-

DTC Latest News

DEFENCE RETAINS CATO SMS TO ADVISE ON ITS  PHASE I CLINICAL TRIAL ON ACCUTOXTM FOR BREAST CANCER

 DEFENCE RETAINS CATO SMS TO ADVISE ON ITS  PHASE I CLINICAL TRIAL ON ACCUTOXTM FOR BREAST CANCER  Vancouver, BC, Canada, February 16th, 2022 -- InvestorsHub NewsWire Defence Therapeutics Inc...

Defence's AccumTM-HPV vaccine formulation (AccuVAC-PT009) activates a 36-fold higher humoral response compared to Gardasil-9

  Defence's AccumTM-HPV vaccine formulation (AccuVAC-PT009) activates a 36-fold higher humoral response compared to Gardasil-9   Vancouver, BC, Canada, January 26th...

DEFENCE THERAPEUTICS VACCINES AND PROGRAM DEVELOPMENT

Vancouver, BC, Canada -- November 30th 2021 -- InvestorsHub NewsWire -- Defence Therapeutics Inc. (CSE: DTC; FSE: DTC; USOTC: DTCFF) ("Defence" or the...

DEFENCE THERAPEUTICS CANCER VACCINE ACCUVAC-D001 MANUFACTURING TARGETS MELANOMA AND BREAST CANCER

DEFENCE THERAPEUTICS CANCER VACCINE ACCUVAC-D001 MANUFACTURING TARGETS MELANOMA AND BREAST CANCER   Vancouver, BC, Canada -- November 23, 2021 -- InvestorsHub NewsWire...

DEFENCE THERAPEUTICS APPOINTS DR. RIAM SHAMMAA TO ITS BOARD OF DIRECTORS

 DEFENCE THERAPEUTICS APPOINTS DR. RIAM SHAMMAA TO ITS BOARD OF DIRECTORS Vancouver, BC, Canada, November 9th, 2021 -- InvestorsHub NewsWire -- Defence Therapeutics Inc. CSE:DTC, USOTC:DTCFF...

VACCINE RESULTS: DEFENCE THERAPEUTICS REPORTS SUCCESSFUL COMPLETION OF ITS COVID-19 VACCINE ACCUVAC-PT001 TOXICOLOGY STUDIES IN RABBITS

  VACCINE RESULTS: DEFENCE THERAPEUTICS REPORTS SUCCESSFUL COMPLETION OF ITS COVID-19 VACCINE ACCUVAC-PT001 TOXICOLOGY STUDIES IN RABBITS   Vancouver, BC, Canada, November...

DEFENCE THERAPEUTICS ACCUMTM VARIANTS IN VITRO STUDY INCREASES THE POTENCY OF T-DERUXTECAN ADC BY 5-FOLD ON BREAST CANCER

  DEFENCE THERAPEUTICS ACCUMTM VARIANTS IN VITRO STUDY INCREASES THE POTENCY OF T-DERUXTECAN ADC BY 5-FOLD ON BREAST CANCER   Vancouver, BC, Canada, October 13th...

DEFENCE THERAPEUTICS PREPARES FOR PHASE I TRIAL TO TEST ITS DC CANCER VACCINE, ACCUVAC-D002, AGAINST MELANOMA

    DEFENCE THERAPEUTICS PREPARES FOR PHASE I TRIAL TO TEST ITS DC CANCER VACCINE, ACCUVAC-D002, AGAINST MELANOMA Vancouver, BC, Canada, October 6th, 2021 -- InvestorsHub NewsWire -- Defence...

DEFENCE THERAPEUTICS TO FINALIZE ITS OBJECTIVES TO INITIATE A PHASE I TRIAL AGAINST BREAST CANCER

 DEFENCE THERAPEUTICS TO FINALIZE ITS OBJECTIVES TO INITIATE A PHASE I TRIAL AGAINST BREAST CANCER Vancouver, BC, Canada, September 29th, 2021 - InvestorsHub NewsWire -- Defence Therapeutics Inc...

DEFENCE THERAPEUTICS SUCCESSFULLY ENGINEERED AND TESTED A NOVEL INTRANASAL COVID-19 VACCINE FORMULATION IN ANIMALS

 DEFENCE THERAPEUTICS SUCCESSFULLY ENGINEERED AND TESTED A NOVEL INTRANASAL COVID-19 VACCINE FORMULATION IN ANIMALS Vancouver, BC, Canada, September 20th, 2021 -- InvestorsHub NewsWire -- Defence...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.1223.07692307690.520.670.52192730.56844345CS
40.0916.36363636360.550.670.49289820.52968947CS
120.058.474576271190.590.670.49254640.56539552CS
26-0.15-18.98734177220.790.960.48313040.65710959CS
52-1.6-71.42857142862.242.550.48292961.05419895CS
156-4.96-88.57142857145.65.650.48194962.0712375CS
260-1.11-63.42857142861.758.150.48185722.53865699CS

DTC - Frequently Asked Questions (FAQ)

What is the current Defence Therapeutics share price?
The current share price of Defence Therapeutics is $ 0.64
What is the 1 year trading range for Defence Therapeutics share price?
Defence Therapeutics has traded in the range of $ 0.48 to $ 2.55 during the past year

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MOSSMoss Genomics Inc
$ 0.16
(3,100.00%)
479.42k
SESweet Earth Holdings Corporation
$ 0.495
(230.00%)
16.55k
IZOIzotropic Corporation
$ 0.115
(187.50%)
81k
ADPTAdaptogenics Health Corp
$ 0.06
(140.00%)
68k
NIRVNirvana Life Sciences Inc
$ 0.05
(100.00%)
14k
ENRTEnertopia Corp
$ 0.005
(-66.67%)
3.35k
ETIEnviroMetal Technologies Inc
$ 0.005
(-50.00%)
59.45k
KVMKingsview Minerals Ltd
$ 0.005
(-50.00%)
106k
WBIOWPD Pharmaceuticals Inc
$ 0.005
(-50.00%)
200k
PSPowerStone Metals Corp
$ 0.04
(-42.86%)
4k
CHGXChitogenX Inc
$ 0.01
(-33.33%)
7.92M
SXSt Georges Eco Mining Corp
$ 0.05
(-9.09%)
2.34M
AIMLAl ML Innovations Inc
$ 0.155
(34.78%)
2.14M
SCPEScope Technologies Corp
$ 1.75
(14.38%)
1.62M
GURNGlobal Uranium Corp
$ 0.92
(5.75%)
1.45M

Your Recent History

Delayed Upgrade Clock